Italy Suspends AstraZeneca COVID-19 Vaccine For People Under 60 Yrs, After Teenager Dies

(RTTNews) - Italy suspended the use of the AstraZeneca COVID-19 vaccine for people under 60 years old, according to several media reports.

The move reportedly came after a teenager died of a blood clot Thursday after receiving an initial dose of the vaccine on May 25.

The media reports indicated that the young woman suffered from autoimmune thrombocytopenia (low blood platelet count) and was on double hormone therapy.

Italy has reportedly instructed that younger people who have already received the first dose of AstraZeneca "the cycle should be completed with a second dose of mRNA vaccine" such as Pfizer-BioNTech or Moderna, administered eight to 12 weeks later.

Italy in March suspended the use of the AstraZeneca vaccine over health fears. But it approved the vaccine for everyone over 18, after the EU's medicines agency gave the green light.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story


Latest Markets Videos


    Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.

    Learn More